FNY Partners Fund’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

FNY Partners Fund’s Portfolio NVET Stock Details NVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,300	Closed	-$15K	–	797
2017 Q2	$15K	Buy	+2,300	New	+$14.5K	﹤0.01%	367

FNY Partners Fund's NVET Position: Q3 2017 in Review

FNY Partners Fund sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q3 2017, closing a stake of 2,300 shares — an estimated $15K sold.

FNY Partners Fund first reported a position in NVET in Q2 2017 and held it in 1 quarter. The position peaked at $15K in Q2 2017. 0 funds tracked by Wall St. Rank hold NVET as of Q3 2017.

FNY Partners Fund reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q3 2017 after selling out during the quarter.
FNY Partners Fund sold 2,300 Nexvet Biopharma plc Ordinary Shares shares in Q3 2017, an estimated $15K.
FNY Partners Fund first reported a position in Nexvet Biopharma plc Ordinary Shares in Q2 2017 and held it in 1 quarter.
FNY Partners Fund's Nexvet Biopharma plc Ordinary Shares position peaked at $15K in Q2 2017.
0 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q3 2017.

Based on FNY Partners Fund's 13F filing for Q3 2017, filed 9 Nov 2017.